<code id='774314F409'></code><style id='774314F409'></style>
    • <acronym id='774314F409'></acronym>
      <center id='774314F409'><center id='774314F409'><tfoot id='774314F409'></tfoot></center><abbr id='774314F409'><dir id='774314F409'><tfoot id='774314F409'></tfoot><noframes id='774314F409'>

    • <optgroup id='774314F409'><strike id='774314F409'><sup id='774314F409'></sup></strike><code id='774314F409'></code></optgroup>
        1. <b id='774314F409'><label id='774314F409'><select id='774314F409'><dt id='774314F409'><span id='774314F409'></span></dt></select></label></b><u id='774314F409'></u>
          <i id='774314F409'><strike id='774314F409'><tt id='774314F409'><pre id='774314F409'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:89769
          Illumina Grail vertical merger
          Adobe

          SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

          The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

          advertisement

          Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Readout Newsletter: Bluebird, CVS, Contineum
          Readout Newsletter: Bluebird, CVS, Contineum

          JustinSullivan/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Readout Newsletter: Geron, Novo Nordisk, WuXi updates

          KayanaSzymczakforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote